As of Aug 26
| +0.06 / +1.54%|
The 2 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +127.85% increase from the last price of 3.95.
The current consensus among 7 polled investment analysts is to Hold stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.